COVIM — Scaling Standardized Immune Profiling Across 25 Sites
Research & Funding Watch #01
Research infrastructure is increasingly moving beyond individual laboratories and instruments.
COVIM is a current example of this shift: a nationwide research infrastructure designed to standardize and scale complex immune profiling across up to 25 sites.
The challenge is not simply to provide access to technologies, but to make scientific workflows reproducible across multiple laboratories.
COVIM
The COllaboratiVe IMmunity Platform of the Network University Medicine (COVIM) is being expanded into a nationwide research infrastructure.
The initiative, jointly coordinated by University Hospital Cologne and Charité – Universitätsmedizin Berlin, has received €10.3 million plus an additional €4.8 million in federal funding.
COVIM is intended to provide standardized and scalable methods for measuring and characterizing complex immune responses across as many as 25 participating sites.
Why it matters
Multicenter research infrastructures face a problem familiar from many technology platforms: installing the same technology is not sufficient to generate comparable results.
Sample handling, assay execution, instrumentation, quality control, data processing and documentation all become part of the infrastructure.
COVIM therefore represents an important example of research capability being scaled not simply through equipment deployment, but through standardized workflows and quality processes across multiple laboratories.
Relevant for:
cell-based assays · immune profiling · workflow standardization · multicenter research · quality systems
Source:
Center for Molecular Medicine Cologne — COVIM infrastructure announcement, 16 September 2026.
CELLIMA perspective
COVIM illustrates a central challenge of distributed research infrastructure:
Comparable technology does not automatically produce comparable results.
Once workflows are scaled across multiple sites, infrastructure includes much more than instrumentation. Sample handling, assay execution, quality control, data processing, documentation and operational interfaces all become part of the scientific system.
For research organizations building shared imaging, screening or assay platforms, this has an important consequence:
Standardization and interoperability need to be designed into the infrastructure from the beginning.
Technology selection therefore cannot be separated from workflow design, data architecture and quality processes.
About the Research & Funding Watch
The CELLIMA Research & Funding Watch tracks selected research initiatives, infrastructure investments and funding developments relevant to advanced imaging, screening, laboratory automation and technology-driven life-science research.
The objective is not to provide a comprehensive news feed, but to identify developments with potential implications for how scientific capabilities and research environments are being built.
